Abstract: The present disclosure relates to a composition comprising umbelliferone and theobromine, and its formulation thereof. The cosmetic composition as disclosed herein is useful for preventing and reducing signs of skin aging.
Claims:1. A composition for cosmetic inhibition of appearance of dermal aging, said composition comprising:
a. umbelliferone; and
b. theobromine,
wherein umbelliferone to theobromine w/w ratio in said composition is in the range of 1:0.005-1:0.02.
2. The composition as claimed in claim 1, wherein umbelliferone to theobromine w/w ratio in said composition is 1:0.01.
3. The composition as claimed in claim 1, wherein umbelliferone weight concentration in said composition is in the range of 0.005-0.01%, and theobromine weight concentration in said composition is in the range of 0.00005-0.0001%.
4. A method of preparing a composition as claimed in any of the claims 1-3.
5. A formulation for cosmetic inhibition of appearance of dermal aging, said formulation comprising:
a. umbelliferone;
b. theobromine, and
c. at least one carrier, diluent, and excipient,
wherein umbelliferone to theobromine w/w ratio in said composition is in the range of 1:0.005-1:0.02.
6. The formulation as claimed in claim 5, wherein umbelliferone to theobromine w/w ratio in said formulation is 1:0.01.
7. A method of preparing a formulation as claimed in any of the claims 5-6.
8. A method for cosmetic reduction in appearance of dermal aging, said method comprising the steps:
a. obtaining a composition as claimed in any of the claims 1-3; and
b. contacting said composition with dermis,
wherein said method reduces appearance of dermal aging.
9. A method for cosmetic reduction in appearance of dermal aging, said method comprising the steps:
a. obtaining a formulation as claimed in any of the claims 5-6; and
b. contacting said formulation with dermis,
wherein said method reduces appearance of dermal aging.
10. A composition as claimed in any of the claims 1-2, optionally further comprising a suitable carrier, diluent , Description:As Attached
| # | Name | Date |
|---|---|---|
| 1 | Form 5 [06-11-2015(online)].pdf | 2015-11-06 |
| 2 | Form 3 [06-11-2015(online)].pdf | 2015-11-06 |
| 3 | Drawing [06-11-2015(online)].pdf | 2015-11-06 |
| 4 | Description(Complete) [06-11-2015(online)].pdf | 2015-11-06 |
| 5 | 6022-CHE-2015-Power of Attorney-120116.pdf | 2016-06-20 |
| 6 | 6022-CHE-2015-Form 1-120116.pdf | 2016-06-20 |
| 7 | 6022-CHE-2015-Correspondence-F1-PA-120116.pdf | 2016-06-20 |
| 8 | 6022-CHE-2015-FORM 18 [27-09-2019(online)].pdf | 2019-09-27 |
| 9 | 6022-CHE-2015-FER.pdf | 2020-03-13 |
| 1 | TPO-2020-02-2412-32-30_24-02-2020.pdf |
| 2 | IntellectualPropertyIndia_24-02-2020.pdf |